J. C. Peart

Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain

David S. Miller, B. Hawkins, R. E. Cannon, 2012, Proceedings of the National Academy of Sciences.